Form 4: Organogenesis Holdings Inc. Insider Transactions: Share Transfer Among Controlling Group Members

A significant transfer of Organogenesis Holdings Inc. Class A Common Stock occurred between members of a controlling group for estate planning purposes, with no change in the total group holdings.

Summary

• On December 31, 2024, Alan A. Ades transferred 1,710,552 shares of Organogenesis Holdings Inc. Class A Common Stock to his spouse, Josette Ades, as a gift.
• This transfer was for estate planning purposes and involved no monetary consideration.
• The shares were previously held directly by Alan A. Ades and are now held by Josette Ades.
• Despite the transfer, the total number of shares held by the controlling group remained unchanged at 51,085,403.
• The controlling group includes Alan A. Ades, Josette Ades, and other related parties.
• This group is party to a Controlling Stockholders' Agreement which grants them nomination rights for four directors of the company.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction for estate planning purposes, with no indication of negative implications for the company. The sentiment is neutral to slightly positive due to the stability of the controlling group's holdings.

Positives

• The transfer is part of estate planning, which is a normal financial activity for individuals.
• The total number of shares held by the controlling group remains unchanged, indicating stability in ownership.

Risks

• While the transfer is for estate planning, any future changes in the controlling group's holdings could impact the company's stock price.
• The controlling group's influence through nomination rights could lead to potential conflicts of interest.

Management Comments

• Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Industry Context

This type of transaction is common among company insiders and large shareholders for personal financial planning and does not indicate any change in the company's operations or strategy.

Comparison to Industry Standards

• Transfers of shares between family members for estate planning are a common practice among corporate insiders.
• The controlling group structure and agreements are not unusual for companies with significant founding or early-stage investors.
• The disclosure of these transactions through SEC Form 4 filings is standard practice for publicly traded companies.

Related Party Transactions

• The transfer of shares between Alan A. Ades and his spouse, Josette Ades, is a related party transaction.

Stakeholder Impact

• The share transfer has no immediate impact on shareholders, employees, customers, or suppliers.
• The controlling group's continued influence through nomination rights remains unchanged.

Key Dates

Keywords

Organogenesis Holdings Inc., insider trading, share transfer, controlling group, estate planning, Class A Common Stock, beneficial ownership, Form 4, director, 10% owner